Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.52 |
| ▸ | HTR2A | P28223 | 1/20 | 0.52 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.42 |
| ▸ | RELA | Q04206 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | HMOX1 | P09601 | 1/20 | 0.42 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.40 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.40 |
| ▸ | IDO1 | P14902 | 2/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.38 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.38 |
| ▸ | PLAAT3 | P53816 | 1/20 | 0.38 |
| ▸ | PLAAT5 | Q96KN8 | 1/20 | 0.38 |
| ▸ | PLAAT2 | Q9NWW9 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28594032 | 0.91 | TAAR1 (0.48) | TAAR1HTR2ASIRT2NPC1NFKB1 | |
| SCHEMBL9552832 | 0.87 | TAAR1 (0.45) | TAAR1HTR2ASIRT2NPC1NFKB1 | |
| SCHEMBL28709923 | 0.87 | MAOB (0.40) | TAAR1HTR2ANFKB1SMN1; SMN2 | |
| SCHEMBL6609033 | 0.85 | MAPK1 (0.44) | TAAR1HTR2ASIRT2NPC1NFKB1 | |
| SCHEMBL9772917 | 0.84 | TDP1 (0.47) | TAAR1HTR2ASIGMAR1PLAAT3PLAAT5 | |
| SCHEMBL44250 | 0.84 | TAAR1 (0.56) | TAAR1HTR2ACYP2A6IDO1 | |
| SCHEMBL5238701 | 0.84 | TAAR1 (0.62) | TAAR1HTR2ANPC1NFKB1MAPK1 | |
| SCHEMBL7904900 | 0.84 | TAAR1 (0.62) | TAAR1HTR2ANPC1NFKB1MAPK1 | |
| SCHEMBL134452 | 0.81 | TAAR1 (0.59) | TAAR1HTR2AHMOX1CYP2A6SIGMAR1 | |
| SCHEMBL30096319 | 0.81 | TAAR1 (0.59) | TAAR1HTR2AHMOX1CYP2A6SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116751105-A | Preparation method of 4-bromocyclopropylbenzene | 爱斯特（成都）生物制药股份有限公司 | 2023-09-15 | — | — | CN | claimed |
| CN-113025231-A | Preparation method of organic silicon resin tackifier | 深圳市盛康泰有机硅材料有限公司 | 2021-06-25 | — | — | CN | claimed |
| CN-112979959-A | Preparation method of organic silicon resin for self-adhesive pouring sealant | 深圳市新泰盈电子材料有限公司 | 2021-06-18 | — | — | CN | claimed |
| CN-116751105-B | Preparation method of 4-bromocyclopropylbenzene | 爱斯特（成都）生物制药股份有限公司 | 2026-03-31 | — | — | CN | disclosed |
| CN-116751105-A | Preparation method of 4-bromocyclopropylbenzene | 爱斯特（成都）生物制药股份有限公司 | 2023-09-15 | — | — | CN | disclosed |
| CN-116751105-A | Preparation method of 4-bromocyclopropylbenzene | 爱斯特（成都）生物制药股份有限公司 | 2023-09-15 | — | — | CN | disclosed |
| CN-111548318-B | Electrochromic compound and electrochromic composition | 株式会社理光 | 2023-06-02 | — | — | CN | disclosed |
| CN-113025231-A | Preparation method of organic silicon resin tackifier | 深圳市盛康泰有机硅材料有限公司 | 2021-06-25 | — | — | CN | disclosed |
| CN-112979959-A | Preparation method of organic silicon resin for self-adhesive pouring sealant | 深圳市新泰盈电子材料有限公司 | 2021-06-18 | — | — | CN | disclosed |
| US-10935862-B2 | Electrochromic compound, electrochromic composition, and electrochromic display element | RICOH COMPANY, LTD. (JP) | 2021-03-02 | — | — | US | disclosed |
| US-20200409182-A1 | OPTICAL ELEMENT AND SPECTACLES | RICOH COMPANY, LTD. (JP) | 2020-12-31 | — | — | US | disclosed |
| US-20170336691-A1 | ELECTROCHROMIC COMPOUND, ELECTROCHROMIC COMPOSITION, AND ELECTROCHROMIC ELEMENT | RICOH COMPANY, LTD. (JP) | 2017-11-23 | — | — | US | disclosed |
| US-20170336691-A1 | ELECTROCHROMIC COMPOUND, ELECTROCHROMIC COMPOSITION, AND ELECTROCHROMIC ELEMENT | RICOH COMPANY, LTD. (JP) | 2017-11-23 | — | — | US | disclosed |
| US-20170336691-A1 | ELECTROCHROMIC COMPOUND, ELECTROCHROMIC COMPOSITION, AND ELECTROCHROMIC ELEMENT | RICOH COMPANY, LTD. (JP) | 2017-11-23 | — | — | US | disclosed |
| WO-2016203773-A1 | ELECTROCHROMIC COMPOUND, ELECTROCHROMIC COMPOSITION, AND ELECTROCHROMIC DISPLAY ELEMENT | RICOH COMPANY, LTD. (JP) | 2016-12-22 | — | — | WO | disclosed |
| US-RE37303-E1 | Imidazole compounds and their therapeutic applications | INSTITUT NATIONAL DEL LA SANTE ET DE LA RECHERCHE MEDICALE (FR) | 2001-07-31 | — | — | US | disclosed |
| US-5708171-A | HISTAMINE H3-RECEPTOR ANTAGONIST | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR) | 1998-01-13 | — | — | US | disclosed |
| US-5559113-A | ANTAGONISTS TO HISTAMINE H3 RECEPTORS, SEDATIVES, ANTICONVULSANTS, ANTIULCER AGENTS | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE | 1996-09-24 | — | — | US | disclosed |
| EP-0025882-A1 | N-Phenylpropyl-substituted azoles, process for their preparation and fungicides containing them | BASF Aktiengesellschaft (DE) | 1981-04-01 | — | — | EP | disclosed |
| US-4226878-A | ANTIINFLAMMATORY, HYPOTENSIVES, ANTIHISTAMINES | KISSEI PHARMACEUTICAL CO., LTD. (JP) | 1980-10-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10935862-B2 | Electrochromic compound, electrochromic composition, and electrochromic display element | RPS23, RPS18, RPL13 | TAAR1 2406/4885HTR2A 1629/4885SIRT2 2655/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.